[1]
A. Mazumdar, A. Das, and D. De, “OPTIMIZING CAR T-CELL THERAPY: THE ROLE OF EZH2 INHIBITORS IN B CELL LYMPHOMAS”, SVU, pp. 90–97, Dec. 2025.